$ELUT
ELUTIA INC.

2022 Q4 Form 10-K Financial Statement

#000155837023004475 Filed on March 23, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $12.67M $49.19M
YoY Change 16.61% 3.79%
Cost Of Revenue $7.671M $29.97M
YoY Change 2.68% 5.63%
Gross Profit $4.994M $19.22M
YoY Change 47.32% 1.05%
Gross Profit Margin 39.43% 39.08%
Selling, General & Admin $8.460M $36.82M
YoY Change 8.8% 12.3%
% of Gross Profit 169.4% 191.56%
Research & Development $2.085M $8.940M
YoY Change -38.24% -3.52%
% of Gross Profit 41.75% 46.51%
Depreciation & Amortization $937.0K $3.733M
YoY Change 0.43% 0.08%
% of Gross Profit 18.76% 19.42%
Operating Expenses $10.55M $50.96M
YoY Change -5.44% 21.18%
Operating Profit -$5.551M -$31.74M
YoY Change -28.48% 37.81%
Interest Expense -$1.561M $5.282M
YoY Change 21.01% -0.79%
% of Operating Profit
Other Income/Expense, Net $4.962M $4.159M
YoY Change 16.21%
Pretax Income -$5.442M -$32.86M
YoY Change -39.88% 32.64%
Income Tax -$2.000K $34.00K
% Of Pretax Income
Net Earnings -$5.440M -$32.90M
YoY Change -39.98% 32.49%
Net Earnings / Revenue -42.95% -66.89%
Basic Earnings Per Share -$2.38
Diluted Earnings Per Share -$0.38 -$2.38
COMMON SHARES
Basic Shares Outstanding 13.83M
Diluted Shares Outstanding 13.83M

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.99M $16.99M
YoY Change -44.1% -44.1%
Cash & Equivalents $16.99M
Short-Term Investments
Other Short-Term Assets $3.015M $3.015M
YoY Change 103.03% 103.03%
Inventory $10.05M $10.05M
Prepaid Expenses
Receivables $6.830M $6.830M
Other Receivables $13.81M $13.81M
Total Short-Term Assets $50.70M $50.70M
YoY Change 6.9% 6.9%
LONG-TERM ASSETS
Property, Plant & Equipment $1.403M $1.403M
YoY Change 16.92% 16.92%
Goodwill
YoY Change
Intangibles $15.07M
YoY Change -18.4%
Long-Term Investments
YoY Change
Other Assets $1.670M $1.670M
YoY Change 2097.37% 2097.37%
Total Long-Term Assets $18.14M $18.14M
YoY Change -8.1% -8.1%
TOTAL ASSETS
Total Short-Term Assets $50.70M $50.70M
Total Long-Term Assets $18.14M $18.14M
Total Assets $68.84M $68.84M
YoY Change 2.49% 2.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.328M $2.328M
YoY Change 47.16% 47.16%
Accrued Expenses $10.10M $10.79M
YoY Change 58.48% 69.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $42.62M $42.62M
YoY Change 63.9% 63.9%
LONG-TERM LIABILITIES
Long-Term Debt $24.26M $24.26M
YoY Change 133.05% 133.05%
Other Long-Term Liabilities $127.0K $6.999M
YoY Change -81.81% -59.4%
Total Long-Term Liabilities $24.39M $31.26M
YoY Change 119.54% 13.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.62M $42.62M
Total Long-Term Liabilities $24.39M $31.26M
Total Liabilities $73.87M $73.87M
YoY Change 37.7% 37.7%
SHAREHOLDERS EQUITY
Retained Earnings -$138.0M
YoY Change 31.31%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.033M -$5.033M
YoY Change
Total Liabilities & Shareholders Equity $68.84M $68.84M
YoY Change 2.49% 2.49%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$5.440M -$32.90M
YoY Change -39.98% 32.49%
Depreciation, Depletion And Amortization $937.0K $3.733M
YoY Change 0.43% 0.08%
Cash From Operating Activities -$5.245M -$21.40M
YoY Change -17.88% 38.55%
INVESTING ACTIVITIES
Capital Expenditures $134.0K $540.0K
YoY Change -636.0% 46.34%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$134.0K -$540.0K
YoY Change 436.0% 46.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $18.62M
YoY Change 570.09%
Cash From Financing Activities 14.27M 8.535M
YoY Change 0.37% 27.18%
NET CHANGE
Cash From Operating Activities -5.245M -21.40M
Cash From Investing Activities -134.0K -540.0K
Cash From Financing Activities 14.27M 8.535M
Net Change In Cash 8.888M -13.41M
YoY Change 13.92% 47.24%
FREE CASH FLOW
Cash From Operating Activities -$5.245M -$21.40M
Capital Expenditures $134.0K $540.0K
Free Cash Flow -$5.379M -$21.94M
YoY Change -15.45% 38.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
317000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
208000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8535000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6711000
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001708527
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3400000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3400000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3400000
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201602Member
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39577
CY2022 dei Entity Registrant Name
EntityRegistrantName
Aziyo Biologics, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-4790334
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
12510 Prosperity Drive
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 370
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Silver Spring
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20904
CY2022 dei City Area Code
CityAreaCode
240
CY2022 dei Local Phone Number
LocalPhoneNumber
247-1170
CY2022 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.001 per share
CY2022 dei Trading Symbol
TradingSymbol
AZYO
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
31067793
CY2022 dei Auditor Firm
AuditorFirmId
238
CY2022 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2022 dei Auditor Location
AuditorLocation
Baltimore, Maryland
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16989000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30393000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
35000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6830000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5996000
CY2022Q4 us-gaap Inventory Net
InventoryNet
10052000
CY2021Q4 us-gaap Inventory Net
InventoryNet
9554000
CY2022Q4 us-gaap Loss Contingency Receivable Current
LossContingencyReceivableCurrent
13813000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3015000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1450000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
50699000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
47428000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1403000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1200000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15069000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18466000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1670000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
76000
CY2022Q4 us-gaap Assets
Assets
68841000
CY2021Q4 us-gaap Assets
Assets
67170000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2328000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1582000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10103000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6375000
CY2022Q4 azyo Payables To Tissue Suppliers Current
PayablesToTissueSuppliersCurrent
3152000
CY2021Q4 azyo Payables To Tissue Suppliers Current
PayablesToTissueSuppliersCurrent
2467000
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
8059000
CY2022Q4 azyo Revenue Interest Obligation Current
RevenueInterestObligationCurrent
8990000
CY2021Q4 azyo Revenue Interest Obligation Current
RevenueInterestObligationCurrent
2750000
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4763000
CY2022Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
17360000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
682000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
42615000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26001000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
24260000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10410000
CY2022Q4 azyo Revenue Interest Obligation Noncurrent
RevenueInterestObligationNoncurrent
5916000
CY2021Q4 azyo Revenue Interest Obligation Noncurrent
RevenueInterestObligationNoncurrent
16540000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
956000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
127000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
698000
CY2022Q4 us-gaap Liabilities
Liabilities
73874000
CY2021Q4 us-gaap Liabilities
Liabilities
53649000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
132939000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
118599000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-137988000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105091000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5033000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13521000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
68841000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67170000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
49187000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
47390000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
29965000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28368000
CY2022 us-gaap Gross Profit
GrossProfit
19222000
CY2021 us-gaap Gross Profit
GrossProfit
19022000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20195000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18825000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16627000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13687000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8940000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9266000
CY2022 us-gaap Legal Fees
LegalFees
5200000
CY2021 us-gaap Legal Fees
LegalFees
276000
CY2022 us-gaap Operating Expenses
OperatingExpenses
50962000
CY2021 us-gaap Operating Expenses
OperatingExpenses
42054000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-31740000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-23032000
CY2022 us-gaap Interest Expense
InterestExpense
5282000
CY2021 us-gaap Interest Expense
InterestExpense
5324000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4159000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3579000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32863000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24777000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-32897000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-24832000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.38
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.38
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.38
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.38
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13832887
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13832887
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10444767
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10444767
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
20831000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
208000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3535000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-24832000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13521000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
78000
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
110000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
317000
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-395000
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
607000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3647000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-32897000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5033000
CY2022 us-gaap Profit Loss
ProfitLoss
-32897000
CY2021 us-gaap Profit Loss
ProfitLoss
-24832000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3733000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3730000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-311000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
3029000
CY2022 azyo Gain Loss On Revaluation Of Revenue Interest Obligation And Other
GainLossOnRevaluationOfRevenueInterestObligationAndOther
4962000
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
115000
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
121000
CY2022 azyo Interest Expense Recorded As Additional Revenue Interest Obligation
InterestExpenseRecordedAsAdditionalRevenueInterestObligation
2908000
CY2021 azyo Interest Expense Recorded As Additional Revenue Interest Obligation
InterestExpenseRecordedAsAdditionalRevenueInterestObligation
2654000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3647000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
3535000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
834000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1170000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
498000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-563000
CY2022 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
13813000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1526000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1442000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4908000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-420000
CY2022 azyo Increase Decrease In Obligations To Tissue Suppliers
IncreaseDecreaseInObligationsToTissueSuppliers
685000
CY2021 azyo Increase Decrease In Obligations To Tissue Suppliers
IncreaseDecreaseInObligationsToTissueSuppliers
172000
CY2022 azyo Increase Decrease Contingent Liability
IncreaseDecreaseContingentLiability
17360000
CY2022 azyo Increase Decrease In Contract With Customer Liability And Other Liabilities
IncreaseDecreaseInContractWithCustomerLiabilityAndOtherLiabilities
-571000
CY2021 azyo Increase Decrease In Contract With Customer Liability And Other Liabilities
IncreaseDecreaseInContractWithCustomerLiabilityAndOtherLiabilities
-552000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21434000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15446000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
540000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
369000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-540000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-369000
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
10089000
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
13753000
CY2022 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-4763000
CY2021 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-1751000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
78000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26000
CY2022 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
25000000
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
468000
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
18615000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2778000
CY2022 azyo Payment Of Interest And Fees On Early Repayment Of Debt
PaymentOfInterestAndFeesOnEarlyRepaymentOfDebt
633000
CY2022 azyo Payments On Revenue Interest Obligation
PaymentsOnRevenueInterestObligation
2075000
CY2021 azyo Payments On Revenue Interest Obligation
PaymentsOnRevenueInterestObligation
2747000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
395000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-13439000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9104000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30428000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39532000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16989000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30428000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
5480000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
4984000
CY2022 azyo Fair Value Of Warrants Issued
FairValueOfWarrantsIssued
607000
CY2021 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
3029000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-32900000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-138000000.0
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21400000
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassifications</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Certain reclassifications have been made to prior year amounts to conform to current year financial statement presentation. The reclassifications relate to the separate presentation of prior year costs related to the FiberCel Litigation. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Such costs were formerly shown as a component of general and administrative expenses in the accompanying consolidated statements of operations.</p>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and assumptions relating to inventories, receivables, long-lived assets, the valuation of stock-based awards, the valuation of the revenue interest obligation, the contingent liability for the FiberCel Litigation and deferred income taxes are made at the end of each financial reporting period by management. Management continually re-evaluates its estimates, judgments and assumptions, and management's evaluation could change. Actual results could differ from those estimates.</p>
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16989000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30393000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
35000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16989000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30428000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
100000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
100000
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7713000
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. At December 31, 2022 and 2021, the Company maintained $17.8 million and $30.9 million, respectively, in bank deposit accounts that are in excess of the $0.25 million insurance provided by the Federal Deposit Insurance Corporation in one federally insured financial institution. The Company has not experienced any losses in such accounts.</p>
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
17800000
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
30900000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3647000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3535000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1716000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1880000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
623000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
834000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6840000
CY2022Q4 us-gaap Inventory Net
InventoryNet
10052000
CY2021Q4 us-gaap Inventory Net
InventoryNet
9554000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6147000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5640000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4744000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4440000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1403000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1200000
CY2022 us-gaap Depreciation
Depreciation
300000
CY2021 us-gaap Depreciation
Depreciation
300000
CY2022 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
200000
CY2021 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
100000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1576000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
682000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
956000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1638000
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.072
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
1000000.0
CY2022 azyo Facility Expenses Excluding Lease
FacilityExpensesExcludingLease
500000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1000000.0
CY2021 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1200000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
774000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
554000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
470000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1798000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
160000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1638000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
682000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
956000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34040000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18971000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15069000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34040000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15574000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18466000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3400000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3400000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3400000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1500000
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2022Q4 azyo Deferred Tax Assets Goodwill
DeferredTaxAssetsGoodwill
2947000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.019
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.016
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.003
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.016
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.004
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.003
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.233
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.251
CY2021Q4 azyo Deferred Tax Assets Goodwill
DeferredTaxAssetsGoodwill
3267000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
19743000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14794000
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
491000
CY2021Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
647000
CY2022Q4 azyo Deferred Tax Assets Acquired Intangible Assets
DeferredTaxAssetsAcquiredIntangibleAssets
1452000
CY2021Q4 azyo Deferred Tax Assets Acquired Intangible Assets
DeferredTaxAssetsAcquiredIntangibleAssets
1174000
CY2022Q4 azyo Deferred Tax Assets Revenue Interest Obligation
DeferredTaxAssetsRevenueInterestObligation
774000
CY2021Q4 azyo Deferred Tax Assets Revenue Interest Obligation
DeferredTaxAssetsRevenueInterestObligation
1347000
CY2022Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
2533000
CY2021Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
1866000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1749000
CY2022Q4 azyo Deferred Tax Assets Tax Deferred Expense Operating Lease Liability
DeferredTaxAssetsTaxDeferredExpenseOperatingLeaseLiability
364000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
669000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2045000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1314000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
32767000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
24409000
CY2022Q4 azyo Deferred Tax Liabilities Operating Lease Right To Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightToUseAssets
350000
CY2022Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
562000
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
200000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
912000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
200000
CY2022Q4 azyo Deferred Tax Assets Net Of Liabilities
DeferredTaxAssetsNetOfLiabilities
31855000
CY2021Q4 azyo Deferred Tax Assets Net Of Liabilities
DeferredTaxAssetsNetOfLiabilities
24209000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31855000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
24209000
CY2022 azyo Deferred Tax Assets Change
DeferredTaxAssetsChange
7600000
CY2021 azyo Deferred Tax Assets Change
DeferredTaxAssetsChange
6200000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
47390000
CY2022 azyo Gross Profit Before Intangible Asset Amortization
GrossProfitBeforeIntangibleAssetAmortization
22619000
CY2021 azyo Gross Profit Before Intangible Asset Amortization
GrossProfitBeforeIntangibleAssetAmortization
22418000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3397000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3396000
CY2022 us-gaap Gross Profit
GrossProfit
19222000
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
300000
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-32897000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24832000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13832887
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13832887
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10444767
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10444767
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.38
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.38
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.38
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.38
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2425015
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1622796
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
49187000
CY2021 us-gaap Gross Profit
GrossProfit
19022000
CY2022 us-gaap Gross Profit
GrossProfit
19222000
CY2021 us-gaap Gross Profit
GrossProfit
19022000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20195000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18825000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16627000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13687000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8940000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9266000
CY2022 us-gaap Legal Fees
LegalFees
5200000
CY2021 us-gaap Legal Fees
LegalFees
276000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-31740000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-23032000
CY2022 us-gaap Interest Expense
InterestExpense
5282000
CY2021 us-gaap Interest Expense
InterestExpense
5324000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4159000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3579000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32863000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24777000

Files In Submission

Name View Source Status
0001558370-23-004475-index-headers.html Edgar Link pending
0001558370-23-004475-index.html Edgar Link pending
0001558370-23-004475.txt Edgar Link pending
0001558370-23-004475-xbrl.zip Edgar Link pending
azyo-20221231.xsd Edgar Link pending
azyo-20221231x10k.htm Edgar Link pending
azyo-20221231x10k004.jpg Edgar Link pending
azyo-20221231x10k008.jpg Edgar Link pending
azyo-20221231x10k009.jpg Edgar Link pending
azyo-20221231x10k010.jpg Edgar Link pending
azyo-20221231x10k011.jpg Edgar Link pending
azyo-20221231xex10d15.htm Edgar Link pending
azyo-20221231xex10d6.htm Edgar Link pending
azyo-20221231xex10d8.htm Edgar Link pending
azyo-20221231xex23d1.htm Edgar Link pending
azyo-20221231xex31d1.htm Edgar Link pending
azyo-20221231xex31d2.htm Edgar Link pending
azyo-20221231xex32d1.htm Edgar Link pending
azyo-20221231xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
azyo-20221231_cal.xml Edgar Link unprocessable
azyo-20221231_lab.xml Edgar Link unprocessable
azyo-20221231_pre.xml Edgar Link unprocessable
azyo-20221231_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
azyo-20221231x10k_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending